東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Autoimmune hypophysitis: Insights fr...

Tzou, Shey-Cherng.

FindBook

Google Book

Amazon

博客來

Autoimmune hypophysitis: Insights from a new mouse model.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Autoimmune hypophysitis: Insights from a new mouse model./
作者:	Tzou, Shey-Cherng.
面頁冊數:	94 p.
附註:	Adviser: Noel R. Rose.
Contained By:	Dissertation Abstracts International68-11B.
標題:	Health Sciences, Immunology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3288546
ISBN:	9780549312741

Autoimmune hypophysitis: Insights from a new mouse model.
Tzou, Shey-Cherng.

Autoimmune hypophysitis: Insights from a new mouse model. - 94 p.

Adviser: Noel R. Rose.

Thesis (Ph.D.)--The Johns Hopkins University, 2008.

Autoimmune hypophysitis (AH) is a rare but increasingly recognized disease often misdiagnosed as a non-secreting pituitary adenoma. Unlike pituitary adenomas, which usually require surgery, AH can be managed medically. A better understanding of the pathogenesis and identification of causative autoantigens can aid in the development of an improved differential diagnosis for AH thus avoiding unnecessary surgery. However, current understanding of AH is hampered by lack of an appropriate animal model that can recapitulate the human disease. To attain this goal, a novel mouse model of experimental autoimmune hypophysitis (EAH) was developed by immunizing female SJL/J mice with mouse pituitary protein extracts. Upon immunization, mice developed severe lymphocytic infiltration that mimicked very closely the human disease. In the early phase of EAH, pituitary glands became enlarged, in keeping with radiological findings of AH patients at presentation. The appearance of multinucleated giant cells in the mid phase of EAH suggests that AH and granulomatous hypophysitis may represent a spectrum of the same disease in the pituitary gland. In the late phase of EAH, pituitary glands became atrophic, indicating that empty sella syndrome maybe an outcome of the disease. Endocrinologically, mice developed adrenal insufficiency and hypothyroidism suggesting that multiple pituitary deficiencies are endpoint outcomes of EAH. Finally, prohormone convertase 2 was identified as a candidate autoantigen in EAH by a proteomic approach that combined 2-dimensional gel electrophoresis, immunoblotting and mass spectrometry. Upon immunization, we found that PC2 can induce pituitary disease, although mild, highlighting its involvement in EAH pathogenesis. In conclusion, our mouse model recapitulates the human pathology and provides new insights to its pathogenesis, establishing a novel platform for future research in AH.

ISBN: 9780549312741Subjects--Topical Terms:

1017716
Health Sciences, Immunology.

Autoimmune hypophysitis: Insights from a new mouse model.
LDR:02760nam 2200265 a 45 001 943710
005 20110520
008 110520s2008 ||||||||||||||||| ||eng d
020 $a 9780549312741
035 $a (UMI)AAI3288546
035 $a AAI3288546
040 $a UMI $c UMI
100 1 $a Tzou, Shey-Cherng. $3 1267747
245 1 0 $a Autoimmune hypophysitis: Insights from a new mouse model.
300 $a 94 p.
500 $a Adviser: Noel R. Rose.
500 $a Source: Dissertation Abstracts International, Volume: 68-11, Section: B, page: 7237.
502 $a Thesis (Ph.D.)--The Johns Hopkins University, 2008.
520 $a Autoimmune hypophysitis (AH) is a rare but increasingly recognized disease often misdiagnosed as a non-secreting pituitary adenoma. Unlike pituitary adenomas, which usually require surgery, AH can be managed medically. A better understanding of the pathogenesis and identification of causative autoantigens can aid in the development of an improved differential diagnosis for AH thus avoiding unnecessary surgery. However, current understanding of AH is hampered by lack of an appropriate animal model that can recapitulate the human disease. To attain this goal, a novel mouse model of experimental autoimmune hypophysitis (EAH) was developed by immunizing female SJL/J mice with mouse pituitary protein extracts. Upon immunization, mice developed severe lymphocytic infiltration that mimicked very closely the human disease. In the early phase of EAH, pituitary glands became enlarged, in keeping with radiological findings of AH patients at presentation. The appearance of multinucleated giant cells in the mid phase of EAH suggests that AH and granulomatous hypophysitis may represent a spectrum of the same disease in the pituitary gland. In the late phase of EAH, pituitary glands became atrophic, indicating that empty sella syndrome maybe an outcome of the disease. Endocrinologically, mice developed adrenal insufficiency and hypothyroidism suggesting that multiple pituitary deficiencies are endpoint outcomes of EAH. Finally, prohormone convertase 2 was identified as a candidate autoantigen in EAH by a proteomic approach that combined 2-dimensional gel electrophoresis, immunoblotting and mass spectrometry. Upon immunization, we found that PC2 can induce pituitary disease, although mild, highlighting its involvement in EAH pathogenesis. In conclusion, our mouse model recapitulates the human pathology and provides new insights to its pathogenesis, establishing a novel platform for future research in AH.
590 $a School code: 0098.
650 4 $a Health Sciences, Immunology. $3 1017716
690 $a 0982
710 2 $a The Johns Hopkins University. $3 1017431
773 0 $t Dissertation Abstracts International $g 68-11B.
790 $a 0098
790 1 0 $a Rose, Noel R., $e advisor
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3288546